{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:35:30Z","timestamp":1761514530491,"version":"3.41.2"},"reference-count":55,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"DOI":"10.1590\/0037-8682-0477-2019","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T15:04:44Z","timestamp":1581087884000},"source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of the Benznidazole+Posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute Chagas"],"prefix":"10.1590","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-3859","authenticated-orcid":false,"given":"Luis Eduardo","family":"Echeverr\u00eda","sequence":"first","affiliation":[{"name":"Fundaci\u00f3n Cardiovascular de Colombia,  Colombia; Fundaci\u00f3n Cardiovascular de Colombia,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara Isabel","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Universidad Industrial de Santander,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio Cesar Mantilla","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Universidad Industrial de Santander,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha Lucia","family":"D\u00edaz","sequence":"additional","affiliation":[{"name":"Universidad Industrial de Santander,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Eduardo Nieto","sequence":"additional","affiliation":[{"name":"Universidad Cooperativa de Colombia,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Alberto","family":"L\u00f3pez-Romero","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Cardiovascular de Colombia,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n David","family":"Rivera","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Cardiovascular de Colombia,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin Uriel","family":"Su\u00e1rez","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Cardiovascular de Colombia,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Alejandro G\u00f3mez","family":"Ochoa","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Cardiovascular de Colombia,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyda Z.","family":"Rojas","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Cardiovascular de Colombia,  Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Morillo","sequence":"additional","affiliation":[{"name":"University of Calgary,  Canada; McMaster University,  Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020]]},"reference":[{"year":"2016","series-title":"La enfermedad de Chagas (tripanosomiasis americana)","key":"ref1"},{"year":"2014","series-title":"Informe final del evento enfermedad de Chagas","key":"ref2"},{"issue":"9723","key":"ref3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi AJ","year":"2010","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.idc.2012.03.002","article-title":"American trypanosomiasis (Chagas disease)","volume":"26","author":"Rassi AJ","year":"2012","journal-title":"Infect Dis Clin North Am"},{"year":"2012","series-title":"Enfermedad de Chagas, memorias","key":"ref5"},{"first-page":"1","year":"2017","series-title":"Bolet\u00edn epidemiol\u00f3gico semanal","key":"ref6"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1186\/s13071-015-1218-2","article-title":"Acute chagas outbreaks: molecular and biological features of Trypanosoma cruzi isolates, and clinical aspects of acute cases in Santander, Colombia","volume":"8","author":"D\u00edaz ML","year":"2015","journal-title":"Parasit Vectors"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7705\/biomedica.v34i4.2204","article-title":"Transmisi\u00f3n oral de Trypanosoma cruzi: una nueva situaci\u00f3n epidemiol\u00f3gica de la enfermedad de Chagas en Colombia y otros pa\u00edses suramericanos","volume":"34","author":"k Rueda","year":"2014","journal-title":"Biom\u00e9dica"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/CIRCULATIONAHA.106.627265","article-title":"Predictors of mortality in chronic Chagas disease: a systematic review of observational studies","volume":"115","author":"Rassi AJr","year":"2007","journal-title":"Circulation"},{"year":"2016","series-title":"Gu\u00eda de atenci\u00f3n de la enfermedad de Chagas","key":"ref10"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/AAC.00779-08","article-title":"Absence of CD4+ T lymphocytes, CD8+ T lymphocytes, or B lymphocytes has different effects on the efficacy of posaconazole and benznidazole in treatment of experimental acute Trypanosoma cruzi infection","volume":"53","author":"Ferraz ML","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1381612023396177","article-title":"Chemotherapy of Chagas disease","volume":"8","author":"Urbina JA","year":"2002","journal-title":"Curr Pharm Des"},{"issue":"1-2","key":"ref13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina JA","year":"2010","journal-title":"Acta Trop"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijantimicag.2012.08.002","article-title":"Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome\u00ae in mice infected with Trypanosoma cruzi strains","volume":"40","author":"Cencig S","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas Disease Drug Discovery: Toward a New Era","volume":"20","author":"Chatelain E","year":"2015","journal-title":"Journal of Biomolecular Screening"},{"issue":"7","key":"ref16","first-page":"1","article-title":"Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo","volume":"6","author":"Batista Dda G","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/infdis\/jit420","article-title":"New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice","volume":"209","author":"Bustamante JM","year":"2014","journal-title":"J Infect Dis"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002367","article-title":"Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments","volume":"7","author":"Diniz LF","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref19","first-page":"1","article-title":"Refining procedures for the administration of substances. Report of the BVAAWF\/FRAME\/RSPCA\/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation\/Fund for the Replacement of Animals in Medical Experiments\/Royal Society for the Prevention of Cruelty to Animals\/Universities Federation for Animal Welfare","volume":"35","author":"Morton DB","year":"2001","journal-title":"Lab Anim"},{"key":"ref20","first-page":"389","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi","volume":"4","author":"Brener Z","year":"1962","journal-title":"Rev Inst Med trop S Paulo"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1258\/002367796780739871","article-title":"Recommendations for euthanasia of experimental animals: Part 1. DGXI of the European Commission","volume":"30","author":"Close B","year":"1996","journal-title":"Lab Anim"},{"key":"ref22","series-title":"Analysis of longitudinal data","author":"Diggle P","year":"2013","edition":"Second ed"},{"key":"ref23","series-title":"Applied longitudinal analysis","author":"Fitzmaurice G","year":"2011","edition":"Second ed"},{"key":"ref24","series-title":"Applied longitudinal data analysis for epidemiology","author":"Jos WT","year":"2013","edition":"Second ed"},{"year":"2015","series-title":"Resolution 008430 October 4th 1993. Based on it, the scientific, technical and administrative regulations are established for investigations in health","key":"ref25"},{"year":"2016","series-title":"Ley 84 de 1989. Por la cual se adopta el estatuto nacional de protecci\u00f3n de los animales, se crean unas contravenciones y se regula lo referente a su procedimiento y competencia","key":"ref26"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/AAC.01170-06","article-title":"The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas\u2019 disease is less dependent on gamma interferon than that of benznidazole","volume":"51","author":"Ferraz ML","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s001090050359","article-title":"Chemotherapy of Chagas\u2019 disease: the how and the why","volume":"77","author":"Urbina JA","year":"1999","journal-title":"J Mol Med Berl Ger"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2015.12.017","article-title":"Current drug therapy and pharmaceutical challenges for Chagas disease","volume":"156","author":"Bermudez J","year":"2016","journal-title":"Acta Trop"},{"issue":"14","key":"ref30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy","volume":"373","author":"Morillo CA","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/clc.22421","article-title":"The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease","volume":"38","author":"Malik LH","year":"2015","journal-title":"Clin Cardiol"},{"issue":"9","key":"ref32","first-page":"854","article-title":"Immunosuppression and Chagas disease; experience from a non-endemic country","volume":"21","author":"Salvador F","year":"2015","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001965","article-title":"Immunosuppression and Chagas disease: a management challenge","volume":"7","author":"Pinazo MJ","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1590\/S0036-46652002000100006","article-title":"Long term evaluation of etiological treatment of chagas disease with benznidazole","volume":"44","author":"Cancado JR","year":"2002","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pt.2003.09.001","article-title":"Specific chemotherapy of Chagas disease: controversies and advances","volume":"19","author":"Urbina JA","year":"2003","journal-title":"Trends Parasitol"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00001432-200112000-00012","article-title":"Specific treatment of Chagas disease: current status and new developments","volume":"14","author":"Urbina JA","year":"2001","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/bjc.1984.176","article-title":"Preclinical pharmacokinetics of benznidazole","volume":"50","author":"Workman P","year":"1984","journal-title":"Br J Cancer"},{"issue":"9039","key":"ref38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(96)04128-1","article-title":"Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection","volume":"348","author":"de Andrade AL1","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1586\/eri.11.31","article-title":"Current status of Chagas disease chemotherapy","volume":"9","author":"Guedes PM1","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpddr.2015.12.001","article-title":"Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain","volume":"6","author":"Cevey \u00c1C","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128707","article-title":"Benznidazole\/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease","volume":"10","author":"Ass\u00edria Fontes Martins T","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijantimicag.2010.03.006","article-title":"A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease","volume":"36","author":"Olivieri BP","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.00689-15","article-title":"Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease","volume":"59","author":"Khare S","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"20","key":"ref44","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease","volume":"370","author":"Molina I","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.44.1.150-155.2000","article-title":"Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts","volume":"44","author":"Molina J","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial","volume":"69","author":"Morillo CA","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jeu.12184","article-title":"Recent Clinical Trials for the Etiological Treatment of Chronic Chagas Disease: Advances, Challenges and Perspectives","volume":"62","author":"Urbina JA","year":"2015","journal-title":"J Eukaryot Microbiol"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/AAC.05785-11","article-title":"Preclinical monitoring of drug association in experimental chemotherapy of Chagas\u2019 disease by a new HPLC-UV method","volume":"56","author":"Moreira da Silva R","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi LS","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/45.6.819","article-title":"A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease","volume":"45","author":"Ara\u00fajo MS","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"ref51","first-page":"721","article-title":"Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.","volume":"63","author":"Andrade SG","year":"1985","journal-title":"Bull World Health Organ"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1128\/AAC.42.10.2549","article-title":"Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi","volume":"42","author":"Michailowsky V","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-6851(99)90035-X","article-title":"Differential tissue distribution of diverseclones of Trypanosoma cruzi in infectedmice","volume":"100","author":"Andrade LO","year":"1999","journal-title":"Mol Biochem Parasitol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-4894(02)00024-3","article-title":"Trypanosoma cruzi: role of host genetic background in the differential tissue distribution of parasite clonal populations","volume":"100","author":"Andrade LO","year":"2002","journal-title":"Experimental Parasitology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.actatropica.2013.03.006","article-title":"Benznidazole prevents endothelial damage in an experimental model of Chagas disease","volume":"127","author":"Molina-Berr\u00edos A","year":"2013","journal-title":"Acta Tropica"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v53\/1678-9849-rsbmt-53-e20190477.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T20:33:24Z","timestamp":1611434004000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822020000100307&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":55,"alternative-id":["S0037-86822020000100307"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0477-2019","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"type":"electronic","value":"1678-9849"},{"type":"print","value":"0037-8682"}],"subject":[],"published":{"date-parts":[[2020]]},"article-number":"e20190477"}}